Jefferies upgraded Rigel Pharmaceuticals (RIGL) to Buy from Hold with a $42 price target
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RIGL:
- Midday Fly By: Broader market bought on dip after tech selloff
- Rigel Pharmaceuticals price target raised to $38 from $32 at Cantor Fitzgerald
- Rigel Pharmaceuticals Reports Strong Q3 2025 Results
- Rigel Pharmaceuticals reports Q3 EPS $1.46, consensus 94c
- Rigel Pharmaceuticals raises FY25 revenue view to $285M-$290M from $270M-$280M